Jane Street Group, LLC Kodiak Sciences Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$7.09 - $89.45 $112,731 - $1.42 Million	15,900 Added 567.86%	18,700 $144,000
Q4 2021 Feb 15, 2022	SELL	$80.85 - $128.49 $121,274 - $192,735	-1,500 Reduced 34.88%	2,800 $237,000
Q3 2021 Nov 16, 2021	SELL	$81.97 - $106.94 $1.41 Million - $1.84 Million	-17,200 Reduced 80.0%	4,300 $413,000
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $1.66 Million - $2.72 Million	21,500 New	21,500 $2 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.